Business Context and Reporting Period
This Form 6-K filing by TNL Mediagene covers the month of December 2025. The report addresses a critical regulatory matter regarding the Company's continued listing on The Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on regulatory compliance status rather than financial performance data.
Material Changes and Regulatory Status
- Nasdaq Listing Decision: On December 23, 2025, the Nasdaq Hearings Panel granted TNL Mediagene's request for continued listing, subject to specific conditions.
- Compliance Deadline: The Company must demonstrate compliance with Listing Rule 5550(a)(2) (the "$1 Bid Price Rule") on or before January 7, 2026.
- Background: The Company previously received a determination letter on November 6, 2025, notifying it of potential delisting due to failure to meet the $1 Bid Price Rule after an 180-day compliance period.
- Remedial Action: The Company presented a compliance plan to the Panel on December 16, 2025, which included a reverse share split previously disclosed in a Form 6-K filed on December 19, 2025.
Outlook, Risks, and Management Commentary
Management notes that the Company will continue to be listed and its shares will continue to trade on Nasdaq pending a final written decision by the Panel after January 7, 2026. The Panel reserves the right to reconsider the exception if any event occurs that calls into question the Company's ability to meet the terms of the exception. The Company is required to provide prompt notification of any significant events during this exception period.
Investor Verification Checklist
- Verify the Company's ability to meet the $1 Bid Price Rule by the January 7, 2026 deadline.
- Monitor for any significant events reported by the Company that could jeopardize the granted listing exception.
- Review the details of the reverse share split plan filed on December 19, 2025, to understand its impact on share price and liquidity.
- Confirm the final written decision from the Nasdaq Panel after January 7, 2026.